Home/Filings/4/0001127602-14-033286
4//SEC Filing

LIPOSCIENCE INC 4

Accession 0001127602-14-033286

CIK 0001168197operating

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 2:51 PM ET

Size

7.6 KB

Accession

0001127602-14-033286

Insider Transaction Report

Form 4
Period: 2014-11-20
Doran Howard JR
DirectorPresident and CEO
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2014-11-20$1.09/sh317,306$345,8640 total
    Exercise: $4.16Exp: 2024-02-03Common Stock (317,306 underlying)
  • Disposition to Issuer

    Common Stock

    2014-11-20$5.25/sh52,884$277,6410 total
Footnotes (3)
  • [F1]Disposed of pursuant to the Merger Agreement and represents shares of the Issuer's common stock underlying restricted stock unit awards.
  • [F2]The option vests over a period of four years, with 1/16 of the shares underlying the option vesting on a quarterly basis, starting May 3, 2014, subject to the reporting person's continuous service with the issuer as of each vesting date.
  • [F3]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $345,863.54, which represents the difference between $5.25 and the exercise price of the option per share.

Issuer

LIPOSCIENCE INC

CIK 0001168197

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001168197

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 2:51 PM ET
Size
7.6 KB